Leap Therapeutics reports stockholder votes: directors elected, equity plan amended, auditor ratified

CYPHERPUNK TECHNOLOGIES INC.

James Cavanaugh, Douglas Onsi, Christian Richard, and Richard Schilsky elected Class I directors with over 16.7 million votes each.
Advisory vote on executive compensation passed with 16,820,682 for, 1,272,059 against, 40,120 abstain.
Amendment to the 2022 Equity Incentive Plan approved with 16,572,103 for, 1,480,150 against, 80,608 abstain.
Ratification of EisnerAmper LLP as independent auditor for fiscal 2024 passed with 25,894,496 for, 71,613 against, 37,856 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.